Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Akinchan Bhardwaj: Exercise Biological Modifier of Vascular Trajectory
Mar 12, 2026, 11:55

Akinchan Bhardwaj: Exercise Biological Modifier of Vascular Trajectory

Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn:

“If exercise were a drug, we would call it multi-target vascular therapy.

Exercise is often framed as ‘cardiovascular risk reduction.’ But that description undersells what it actually does.

Exercise is not simply a statistical modifier of event probability.

It is a biological modifier of vascular trajectory.

Regular physical activity has been shown to:

  • Improve endothelial nitric oxide bioavailability
  • Reduce systemic inflammatory tone
  • Enhance insulin sensitivity independent of weight loss
  • Improve autonomic balance and blood pressure variability
  • Influence plaque phenotype toward more stable morphology

Most pharmacologic therapies act on a single pathway.

Exercise simultaneously influences lipid metabolism, inflammation, metabolic pressure and vascular function.

If cardiovascular risk is a curve, exercise does not just shift it downward. It reduces its slope.

That distinction matters as we rethink prevention in an era of genomics, AI and precision risk modeling.

I explore this in my latest CardioForesight essay:
‘Exercise Doesn’t Just Lower Risk, It Changes Vascular Biology.'”

Akinchan Bhardwaj

Stay updated with Hemostasis Today.